Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - oestradiol 17 beta - parenteral implant, device - oestradiol 17 beta steroid-estrogen active 43.9 mg/do - nutrition & metabolism - heifer (vealer) | heifer speyed (neutered young cow) | steer (castrated male cattle) | beef | bovine | bullock (young) | male ca - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - oestradiol 17 beta - parenteral implant, device - oestradiol 17 beta steroid-estrogen active 25.7 mg/do - nutrition & metabolism - heifer (vealer) | heifer speyed (neutered young cow) | steer (castrated male cattle) | beef | bovine | bullock (young) | male ca - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - cobalt (ii) sulfate; propylene glycol; choline chloride - oral solution/suspension - cobalt (ii) sulfate mineral-cobalt active 1.1 g/l; propylene glycol solvent active 832.0 g/l; choline chloride vitamin-b complex active 20.6 g/l - nutrition & metabolism - cattle | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | heifer | h - corticosteroid | ketosis | acetonaemia | advancing parturition | allergic reactions | antiadrenal suppression | anti-inflammatory | antishock | arthritis | bronchitis | catabolic complications | chronic bronchitis | corticosteroids | corticosteroids and relate | coughs | dermatitis | dermatological disorders | dermatoses | eczema | elevated ketones | glucogenic steroid | joint disease | ketosis | locomotive diseases | musculo skeletal inflammat | non-clinical ketosis | orthopaedic | parturient udder oedema | parturition | pruritis | respiratory tract diseases | rheumatic diseases | stress | toxaemia | water retention

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - phenmedipham - herbicide - beet | mangold | strawberry - non-fruiting | beetroot | fodder beet | strawberry runner | sugar beet - barley grass | bellvine | blackberry nightshade | charlock | chickweed | cleavers | common fumitory | common groundsel | common thornapple | corn spurry | deadnettle | fat hen | field bindweed | green amaranth | lesser swinecress or bittercress | penny cress | perennial pigweed | persicaria | potato or yellow weed | prairie or annual prairie grass | redshank,slim or spleen amaranth | shepherd's purse | sow or milk thistle | stinging or dwarf nettle | summer or crab grass | wild radish or radish weed | winter grass | wireweed, knotweed or hogweed | yellow alkanna or alkanet | alkanna lutea | amaranthus cruentus | annual bindweed | annual blue grass | annual dwarf nettle | annual nettle | annual poa | annual summer grass | bastard cress | black nightshade | brassica kaber | brassica sinapistrum | bromus catharticus | bromus stamineus | bromus wildenowii | common bindweed | common chickweed | common sowthistle | cornbine (uk) | devil's thornapple | dwarf nettle | english stinging nettle | european bindweed | fal

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

koppers carbon materials & chemicals pty ltd - creosote - high temperature - liquid - creosote - high temperature coal tar active 1044.0 g/l - mixed function pesticide - cross-arm bolt holes & interfaces | pole ground-line | timber | timber - fresh & salt water structure | timber - structure | tim - insect | termite - mastotermes spp. | wood fungus | giant northern termite | mastotermes darwiniensis | wood decaying fungi | wood rot | wood rotting fungi | wood staining fungi | wood-destroying fungi

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - deslorelin as deslorelin acetate - parenteral liquid/solution/suspension - deslorelin as deslorelin acetate ungrouped active 1.25 mg/ml - endocrine system

Kanada - Ingliż - Health Canada

alpha tech pet inc. - didecyl dimethyl ammonium chloride; benzalkonium chloride - liquid - 2.31%; 1.54% - didecyl dimethyl ammonium chloride 2.31%; benzalkonium chloride 1.54% - disinfectants (for agents used on object)

Stati Uniti - Ingliż - Ecolab

ecolab deutschland gmbh -

Stati Uniti - Ingliż - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose 25 mg - acarbose tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose tablets are contraindicated in patients with known hypersensitivity to the drug. acarbose tablets are contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose tablets are contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose 50 mg - acarbose tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose tablets are contraindicated in patients with known hypersensitivity to the drug. acarbose tablets are also contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose tablets are contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.